The new panel facilitates accurate detection of loss of heterozygosity, mosaicism, and copy-number variants in addition to the single-nucleotide variants and insertions/deletions more traditionally assayed by NGS.
Read More
Sentinel’s real-time PCR assays will be adapted to the NeuMoDx 96 and 288 molecular systems and will incorporate Sentinel’s Stat-Nat technology.
Read More
The partnership combines Caris’ somatic and Ambry’s germline testing to provide unique information about the molecular and genetic components of a patient’s cancer.
Read More
With a larger draw volume and low hemolysis, cfDNA/cfRNA and cellular gDNA/RNA can be extracted from the same tube, allowing the user to pair results from the same sample.
Read More
FoundationOne CDx is the only FDA-approved comprehensive genomic profiling test for all solid tumors that incorporates multiple companion diagnostics.
Read More